Table 2 provides details regarding the main outcomes of studies that investigated the role of Gal-3 in predicting myocardial fibrosis, as well as cardiovascular complications, in subjects who underwent CHD corrective surgery. The gene discussed is LGALS3; the disease is Myocardial fibrosis.